Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(i,j)quinolizine-2-carboxylic Acid
2. S 25930
3. S-25930
1. Ibafloxacine
2. 91618-36-9
3. Ibaflin
4. R-835
5. S-25930
6. R835
7. 53vpk9r0t5
8. R 835
9. R835;s25930
10. S25930
11. 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid
12. S 25930
13. Ibafloxacino
14. Ibafloxacinum
15. 1h,5h-benzo(ij)quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-
16. Ibafloxacine [inn-french]
17. Ibafloxacinum [inn-latin]
18. Ibafloxacino [inn-spanish]
19. Unii-53vpk9r0t5
20. Ibafloxacin [usan:inn:ban]
21. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-
22. Ibafloxacin [mi]
23. Ibafloxacin [inn]
24. Ibafloxacin (usan/inn)
25. Ibafloxacin [usan]
26. Dsstox_cid_31642
27. Dsstox_rid_97526
28. Ibafloxacin [mart.]
29. Dsstox_gsid_57853
30. Schembl154637
31. Chembl170052
32. Dtxsid8057853
33. Gtpl10819
34. Tox21_113686
35. Hy-u00214
36. Cs-7344
37. Fluoro-dimethyl-oxo-[?]carboxylic Acid
38. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid
39. Ibafloxacin [ema Epar Veterinary]
40. Ncgc00249910-01
41. Cas-91618-36-9
42. D04485
43. Q5983609
44. 6,7-dihydro-5,8-dimethyl-9- Fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid
45. 7-fluoro-8,12-dimethyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid
| Molecular Weight | 275.27 g/mol |
|---|---|
| Molecular Formula | C15H14FNO3 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 275.09577147 g/mol |
| Monoisotopic Mass | 275.09577147 g/mol |
| Topological Polar Surface Area | 57.6 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
* Dogs: :
Ibaflin is indicated for the treatment of the following conditions in dogs:
- dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains of Staphylococci, Escherichia coli and Proteus mirabilis;
- acute, uncomplicated urinary-tract infections, caused by susceptible strains of Staphylococci, Proteus species, Enterobacter spp. , E. coli and Klebsiella spp. ;
- respiratory-tract infections (upper tract) caused by susceptible strains of Staphylococci, E. coli, and Klebsiella spp.
Ibaflin gel is indicated in dogs for the treatment of the following conditions:
- dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli and P. mirabilis.
* Cats: :
Ibaflin gel is indicated in cats for treatment of the following conditions:
- dermal infections (soft-tissue infections - wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Proteus spp. and Pasteurella spp. ;
- upper respiratory-tract infections caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Klebsiella spp. and Pasteurella spp.
QJ01MA96
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
